These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35415847)
1. Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without non-Hodgkin lymphoma. Zhuang K; Zhang Y; Mo P; Deng L; Jiang Y; Yu L; Mei F; Huang S; Chen X; Yan Y; Tang H; Li X; Xiong Y; Wu S; Ke H; Gui X; Lan K J Med Virol; 2022 Aug; 94(8):3876-3889. PubMed ID: 35415847 [TBL] [Abstract][Full Text] [Related]
2. A novel plasma proteomic-based model for predicting liver fibrosis in HIV/HBV co-infected adults. Yuan R; Zhang Y; Deng L; Yu X; Zhuang K; Chen X; Cao Q; Ping H; Ke H; Gui X; Yang R J Med Virol; 2023 Jan; 95(1):e28222. PubMed ID: 36237173 [TBL] [Abstract][Full Text] [Related]
3. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946 [TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster. Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological investigation and proteomic profiling of typical TCM syndrome in HIV/AIDS immunological nonresponders. Ji SX; Zheng YF; Li X; Li BX; Zou JX; Wang YT; Xia XY; Chen X; Hu QN; Wan TJ; Wen L; Feng QS Anat Rec (Hoboken); 2023 Dec; 306(12):3106-3119. PubMed ID: 35775967 [TBL] [Abstract][Full Text] [Related]
6. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. Gail MH; Pluda JM; Rabkin CS; Biggar RJ; Goedert JJ; Horm JW; Sondik EJ; Yarchoan R; Broder S J Natl Cancer Inst; 1991 May; 83(10):695-701. PubMed ID: 2023270 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776 [TBL] [Abstract][Full Text] [Related]
8. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. Vendrame E; Martínez-Maza O J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858 [TBL] [Abstract][Full Text] [Related]
9. Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry. Ke H; Yuan R; Liu H; Luo M; Hu H; Zhang E; Zhuang K; Yang Y; Yang R Front Immunol; 2023; 14():1282469. PubMed ID: 38022651 [TBL] [Abstract][Full Text] [Related]
10. Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma. Repetto O; De Re V; Mussolin L; Tedeschi M; Elia C; Bianchi M; Buffardi S; Sala A; Burnelli R; Mascarin M Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235718 [TBL] [Abstract][Full Text] [Related]
11. AIDS-related lymphoma of the oral cavity. Colmenero C; Gamallo C; Pintado V; Patron M; Sierra I; Valencia E Int J Oral Maxillofac Surg; 1991 Feb; 20(1):2-6. PubMed ID: 2019778 [TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk. Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M Front Immunol; 2023; 14():1259007. PubMed ID: 37809067 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Levine AM; Sadeghi S; Espina B; Tulpule A; Nathwani B Cancer; 2002 Mar; 94(5):1500-6. PubMed ID: 11920507 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F; Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091 [TBL] [Abstract][Full Text] [Related]
15. Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Boyle MJ; Swanson CE; Turner JJ; Thompson IL; Roberts J; Penny R; Cooper DA Br J Haematol; 1990 Dec; 76(4):506-12. PubMed ID: 2265114 [TBL] [Abstract][Full Text] [Related]
17. Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection. Spina M; Carbone A; Vaccher E; Gloghini A; Talamini R; Cinelli R; Martellotta F; Tirelli U Clin Infect Dis; 2004 Jan; 38(1):142-4. PubMed ID: 14679461 [TBL] [Abstract][Full Text] [Related]
18. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584 [TBL] [Abstract][Full Text] [Related]
19. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Franceschi S; Dal Maso L; La Vecchia C Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of HIV-associated non-Hodgkin lymphoma. Killebrew D; Shiramizu B Curr HIV Res; 2004 Jul; 2(3):215-21. PubMed ID: 15279585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]